Ling Qin

The Distinct Performances of Ultrasound, Mammograms, and MRI in Detecting Breast Cancer in Patients With Germline Pathogenic Variants in Cancer Predisposition Genes

Y. Ming, Hengqiang Zhao, J. Ying, 2021, Frontiers in Oncology.

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets

Mengjiao Huang, Dongliao Fu, Q. Yin, 2022, Translational oncology.

DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data

Jun Yu Li, Shu Liu, Zhihong Wu, 2022, Genome medicine.

ABO Blood Group and the Risk and Prognosis of Lymphoma

D. Gao, JingJing Wang, Dongliao Fu, 2023, Journal of inflammation research.

Anti-vascular endothelial growth factor therapy in breast cancer: Molecular pathway, potential targets, and current treatment strategies.

Jiaqi Liu, Xin Wang, Z. Jia, 2021, Cancer letters.